Cohort #4 might show some adverse effects if the level is too high. But, OTOH, it might show enhanced effectiveness compared to the 30 microgram dose.
I can’t wait for the results!!
Ditto for the MAD trial, but that is a long way off.
Cohort #4 might show some adverse effects if the level is too...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.010(0.81%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.26 | $1.22 | $457.1K | 367.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9084 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 4740 | 4 |
View Market Depth
| Last trade - 11.44am 01/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |